Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nishant Patel

Vascular & Interventional Radiology Englewood, CO Medical Doctor

NPI 1780947531 CMS profile 4999961

10800 E Geddes Ave Ste 300, Englewood, CO 80112

Open in the dashboard

General payments

$19,242

129 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nishant Patel of Englewood, CO is reported in the CMS Open Payments database as having received $19,242 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,733 24
2024 General $950 20
2023 General $1,331 23
2022 General $9,704 24
2021 General $3,658 15
2020 General $850 11
2019 General $1,015 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nishant Patel
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Nishant Patel were reported at $1,733. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Nishant Patel Vascular & Interventional Radiology median Middle half National median
2019 $1,015 $422 $125–$1,555 $163
2020 $850 $200 $68–$652 $114
2021 $3,658 $280 $99–$866 $132
2022 $9,704 $433 $137–$1,497 $149
2023 $1,331 $506 $152–$2,019 $160
2024 $950 $556 $175–$1,930 $164
2025 $1,733 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $14,388 33 payments
  2. Boston Scientific Corporation $1,402 23 payments
  3. Biocompatibles, Inc. $695 6 payments
  4. Stryker Corporation $417 9 payments
  5. Covidien LP $385 1 payment
  6. Medtronic, Inc. $354 9 payments
  7. Asahi Intecc Co., Ltd. $337 1 payment
  8. W. L. Gore & Associates, Inc. $175 7 payments
  9. Asahi Intecc USA, Inc. $160 2 payments
  10. Bard Peripheral Vascular, Inc. $159 7 payments
  11. Other $770 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $11,848 7 payments
  2. Food and Beverage $7,043 119 payments
  3. Travel and Lodging $351 3 payments
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $17,218 33 payments
  2. FLOWTRIEVER CATHETER, S $11,047 31 payments
  3. TheraSphere Y90 Glass Microspheres 10 GBq $465 3 payments
  4. THERASPHERE - BIO $449 4 payments
  5. ClotTriever $403 3 payments
  6. FlowTriever $403 3 payments
  7. THERASPHERE-BIO $246 2 payments
  8. TheraSphere Administration Set $221 3 payments
  9. ClosureRFG $213 1 payment
  10. SpyScope DS $170 1 payment
  11. Other $2,280 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

35

Median for Interventional Radiology: 38

Drug cost

$265

Median for Interventional Radiology: $333

Branded share of claims

0%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cefdinir Generic 11 $124
Methylprednisolone Generic 11 $88
Oxycodone Hcl Generic 13 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 263 billing codes

Paid by Medicare

$163,988

Of which drugs: $372

Medicare patients

2,510

Average age 75

Services billed

5,324

1,395 women, 1,115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Chronic kidney disease 34%
Ischemic heart disease 33%
Depression 32%
Diabetes 31%
Heart failure 27%
COPD 27%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 21 1,542 $161

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record